Evidence map›Paper›PMID 38233934›Full record

Observational studyJournal of translational medicine2024

Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection.

Gennaro Quarto, Giacomo Benassai, Annamaria Colao, Antonio Cittadini, Paolo Antonio Ascierto, Rosario Pivonello, Andrea Elefante, Marialuisa Bocchino, Alberto Maria Marra, Ivan Gentile and 5 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Gennaro Quarto *Department of Clinical Medicine and Surgery, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy. gquarto@unina.it.ORCID 0000-0001-5699-150X
Giacomo Benassai *Department of Clinical Medicine and Surgery, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.
Annamaria Colao *Department of Clinical Medicine and Surgery, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.
Antonio Cittadini *Department of Translational Medicine, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.
Paolo Antonio Ascierto *Melanoma and Cancer Immunotherapy and Developmental Unit, National Cancer Institute IRCCS Fondazione Pascale, Via Mariano Semmola 53, 80131, Naples, Italy.
Rosario Pivonello *Department of Clinical Medicine and Surgery, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.
Andrea Elefante *Department of Advanced Biomedical Sciences, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.
Marialuisa Bocchino *Department of Clinical Medicine and Surgery Section of Respiratory Diseases, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.
Alberto Maria Marra *Department of Translational Medicine, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.
Ivan Gentile *Department of Clinical Medicine and Surgery, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.
Gianluca Benassai *Department of Clinical Medicine and Surgery, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.
Andrea Miletti *Department of Clinical Medicine and Surgery, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.
Francesca Calemma *Department of Clinical Medicine and Surgery, Federico II University, Via Sergio Pansini 5, 80131, Naples, Italy.
Ermenegildo Furino *Department for Integrated Activities of Emergency-Admission, Critical Areas and Trauma, Umberto I University Polyclinic - Sapienza University, Viale del Policlinico 155, 00186, Rome, Italy.
members of FACTA study group
Federico II University Hospital · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITPoliclinico Umberto I · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn observational study involving patients recovered from COVID-19 was conducted in order to evaluate the presence/absence of vein wall thickness increasing, according to the severity of pulmonary involvement quantified with a CT-scoring system.

methodsThe venous wall thickness (VWT) of 31 patients (23 males and 8 females) with COVID 19 previously admitted to Federico II University Hospital of Naples was evaluated through ultrasound measurement of the common femoral Vein 1 cm proximal to the saphenous-femoral junction and the popliteal Vein 1 cm distal to the confluence of gemellary veins. Measurements were taken with an automated tool to avoid human error. All patients were evaluated in the supine position. Patients were then stratified into two groups, VWT > 1 mm and VWT < 1 mm. Lung damage was assessed through thoracic High Resolution Computer Tomography and subsequently quantified using the scoring system set out by Chung et al. CEAP-C class was calculated for all patients.

resultsThe mean value of COVID score in VWT > 1 mm group was 7.4 (S.D. 4.83), whilst the mean value of the COVID score in the VWT < 1 mm group was 3.82 (S.D 3.34). These findings were determined to be statistically significant in a two-tie Student-T test. The linear regression test between VWT and Covid score values demonstrated a direct relationship between the two variables.

conclusionThese results demonstrate a link between two different aspects of the pathological effects on the vessels during a SARS-COV 2 infection. As such a common primum movens can be hypothesized in both micro-thrombotic and inflammatory processes relating to COVID 19.

Indexed as

COVID-19FemaleHumansLungMaleUltrasonographyVeinsARDSChronic venous diseaseChronic venous insufficiencyCOVID-19Vein wall thickness

Identifiers

PMID38233934
PMCPMC10795284
OpenAlexW4390940960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.